Bright Minds Biosciences (DRUG) Return on Capital Employed (2024)

Bright Minds Biosciences (DRUG) posted Return on Capital Employed of 9.35% for Q4 2024.

Bright Minds Biosciences (DRUG) Return on Capital Employed (2024) Analysis & Trends

Bright Minds Biosciences' Return on Capital Employed history runs 1 years deep, the most recent figure standing at 9.35% for Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROCE (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-31.80%
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	10.46%
4	NuCana	279.75 Bn	279.75 Bn	-	-68.47%
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	21.10%
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	10.19%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-68.84%
10	Bright Minds Biosciences	498.53 Mn	498.53 Mn	-	-

Download Data

Date	Value
Dec 31, 2024	-9.35%